Where psychology meets physiology: Chronic stress and premature mortality - The Central-Eastern European health paradox

Brain Research Bulletin

Volumn 62, Issue 5, 2004, Pages 351-367

  Kopp, Mária S ^a   Réthelyi, János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiovascular risk; Depression; Learned helplessness; Perceived control; Psychological models; Transforming societies

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE RECEPTOR; CORTICOSTEROID; CORTICOTROPIN; DOPAMINE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 6; NORADRENALIN; PYRIDOXINE; SEROTONIN; TESTOSTERONE;

ADRENAL MEDULLA; ADRENERGIC SYSTEM; ALCOHOL CONSUMPTION; ANXIETY; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; BONE MINERAL; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; COGNITION; COPING BEHAVIOR; CORONARY ARTERY DISEASE; CORTICOSTEROID BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; EMOTION; EUROPE; EXHAUSTION; FEAR; HEART DISEASE; HEART INFARCTION; HEART RATE VARIABILITY; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ISCHEMIC HEART DISEASE; LEARNED HELPLESSNESS; MAJOR DEPRESSION; MELANCHOLIA; MENTAL HEALTH; MENTAL STRESS; MORBIDITY; MORTALITY; NERVE CELL LESION; NEUROTRANSMISSION; NONHUMAN; NUTRITIONAL STATUS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SOCIAL ISOLATION; SOCIAL PROBLEM; SOCIOECONOMICS; SURVIVAL RATE;

EID: 1042267366     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2003.12.001     Document Type: Review

References (162)

1. Abramson L.Y., Metalsky G.I., Alloy L.B. Hopelessness depression: a theory based subtype of depression. Psychol. Rev. 96(2):1989;358-372.
2. Appels A. Depression and coronary heart disease: observations and questions. J. Psychosom. Res. 43:1997;443-452.
3. Appels A., Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur. Heart J. 9:1988;758-764.
4. Bandura A. Self-efficacy conception of anxiety. Anxiety Res. Ann. Int. J. 1:1988;77-98.
5. A. Bandura, Self-efficacy: the exercise of control, Freeman, New York, 1997.
6. Barefoot J.C., Brumett B.H., Helms M.J., Mark D.B., Siegler I.C., Williams R.B. Depressive symptoms and survival of patients with coronary artery disease. Psychosom. Med. 62:2000;790-795.
7. Berkman L.F., Blumenthal J., Burg M., Carney R.M., Catellier D., Cowan M.J., Czajkovski S.M., DeBusk R., Hosking J., Jaffe A., Kaufmenn P.G., Mitchell P., Norman J., Powell L.H., Raczynski J.M., Schneidermann N. Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD) Writing Committee: effects of treating depression and low perceived social support on clinical events after myocardial infarction. The Enhancing Recovery in Coronary Heart Disease Patients ENRICHD randomized trial. JAMA. 289(23):2003;3106-3116.
8. Bjorntorp P. Body fat distribution, insulin resistance and metabolic diseases. Nutrition. 13(9):1997;795-803.
9. D. Black, J.N. Morris, C. Smith, P. Townsend, M. Whitehead, Inequalities in Health: The Black Report, Health Divide, Penguin, London, 1992.
10. Bobak M., Marmot M. East-est mortality divide: proposed research agenda. Br. Med. J. 312:1996;421-425.
11. Bobak M., Pikhart H., Rose R.et al. Socioeconomic factors, material inequalities and perceived control in self-rated health: cross sectional data from seven post-communist countries. Soc. Sci. Med. 5:2000;1343-1350.
12. J. Bowlby, Attachment and Loss, vol. 1, Attachment Basic Books, New York, 1969.
13. Breslau N., Davis G.C. Chronic stress and major depression. Arch. Gen. Psych. 43:1986;309-314.
14. Camacho A., Dimsdale J.E. Platelets and psychiatry: lessons learned from old and new studies. Psychosom. Med. 62:2000;326-336.
15. Cannon W.B. Voodoo death. Am. Anthropol. 44:1942;169-181.
16. Clouse R.E., Lustman P.J., Freedland K.E., Griffith L.S., McGill J.B., Carney R.M. Depression and coronary heart disease in women with diabetes. Psychosom. Med. 65:2003;376-383.
17. Cole S.R., Kawachi I., Sesso H.D., Paffenbarger R.S., Lee I.M. Sense of exhaustion and coronary heart disease among college alumni. Am. J. Cardiol. 84(12):1999;1401-1405.
18. J. Coleman, Foundations of Social Theory, Harvard University Press, Cambridge, MA, 1990.
19. G.A. Cornia, R. Panicia (Eds.), The Mortality Crisis in Transitional Economies, Oxford, 2000.
20. Csermely P. Chaperone, overload as a possible contributor to civilization diseases: atherosclerosis, cancer, diabetes. Trends Genet. 17:2001;701-704.
21. Danner M., Kasl S.V., Abramson J.L., Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom. Med. 65:2003;347-356.
22. A. DeLongis, M. Preece, Coping skills, in: E.G. Fink (Ed.), Encyclopedia of Stress, Academic Press, San Diego, 2000, pp. 532-541.
23. Dinan T.G. Physical consequences of depression. Br. Med. J. 318:1999;826.
24. Dixon A.K. Ethological strategies for defence in animals and humans: their role in some psychiatric disorders. Br. J. Med. Psychol. 71:1998;417-445.
25. Elenkov I.J., Wilder R.L., Chroussos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:2000;595-638.
26. E. Endrõczi, Stress and Adaptation, Akadémia, Budapest, 1991.
27. Everson S.A., Goldberg D.E., Kaplan G.A., Cohen R.D., Pukkala E., Tuomilehto J., Salonen J.T. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom. Med. 58:1996;113-121.
28. Everson S.A., Kaplan G.A., Goldberg D.E., Salonen J.T. Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension. 35(2):2000;561-567.
29. Everson S.A., Kaplan G.A., Goldberg D.E., Salonen R., Salonen J.T. Hopelessness and 4 year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler. Thromb. Vasc. Biol. 17(8):1997;1490-1495.
30. Falger P.R.J., Schouten E.G.W. Exhaustion, psychological stressors in the work environment, and acute myocardial infarction among active men. J. Psychosom. Res. 36:1992;777-786.
31. Ferketich A.K., Schwartzbaum J.A., Frid D.J., Moeschberger M.L. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch. Int. Med. 160:2000;1261-1268.
32. M.B. First (Ed.), DSM-IV Text Revision, Task Force on DSM-IV, 2000.
33. P. Fonagy, Patterns of attachment, interpersonal relationships and health, in: D. Blane, E. Brunner, R. Wilkinson (Eds.), Health and Social Organization, Routledge, New York, 1996.
34. Frasure-Smith N., Lesperance F., Talajic M. Depression and 18 month prognosis after myocardial infarction. Circulation. 91:1995;999-1005.
35. Glassman A.H., Shapiro P.A. Depression and the course of coronary artery disease. Am. J. Psychiatry. 155(1):1998;4-11.
36. Gold P.W., Chroussos G.P. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc. Assoc. Am. Phys. 111(1):1998;22-34.
37. P.W. Gold, F.K. Goodwin, G.P. Chroussos, Clinical and biochemical manifestations of depression-relation to neurobiology of stress, N. Eng. J. Med. 319 (6) (1988) 348-353, (7) 413-420.
38. Gould K.L., Ornish D., Scherwitz L., Brown S., Edens P., Hess M.J., Mullani N., Bolomey L., Dobbs F., Armstrong W.T., Merritt T., Ports T., Sparler S., Billings J. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 274(11):1995;894-901.
39. Haller J., Bakos N., Rodriguiz R.M., Caron M.G., Wetsel W.C., Liposits Z.S. Behavioural responses to social stress in noradrenalin transporter knockout mice: effects on social behaviour and depression. Brain Res. Bull. 58(3):2002;279-284.
40. Haller J., Halász J. Anxiolytic effects of repeated victory in male wistar rats. Aggress. Behav. 26:2000;257-261.
41. Health for all (HFA) Data Base, WHO Regional Office for Europe, Copenhagen, 1999.
42. Heim C.H., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress related bodily disorders. Psychoneuroendocrinology. 25:2000;1-35.
43. Hemingway H., Marmot M. Evidence-based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. Br. Med. J. 318:1999;1460-1467.
44. Horrobin D.F., Bennett C.N. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer. Leukot. Essent. Fatty Acids. 60(4):1999;217-234.
45. Huether G. The central adapatation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain function. Progr. Neurobiol. 48:1996;569-612.
46. Hyland M.E. Control theory interpretation of psychological mechanisms of depression: comparison and integration of several theories. Psychol. Bull. 102(1):1987;109-121.
47. Idler E.L., Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J. Health Soc. Behav. 38:1997;21-37.
48. Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosom. Med. 62:2000;463-471.
49. Kaplan G.A. Where do shared pathways lead? Psychosom. Med. 57:1995;208.
50. Kaplan G.A., Pamuk E.R., Lynch J.W., Cohen R.D., Balfour J.L. Inequality in income and mortality in the United Satates: analysis of mortality and potential pathways. Br. Med. J. 312:1996;999-1003.
51. I. Kawachi, L.F. Berkman, Social cohesion, social capital, and health, in: L.F. Berkman, I. Kawachi (Eds.), Social Epidemiology, Oxford University, New York, 2000.
52. Kawachi I., Kennedy B.P. Health and social cohesion: why care about income inequality? Br. Med. J. 314:1997;1037-1040.
53. Kawachi I., Kennedy B.P., Lochner K., Prothrow-Stith D. Social capital, income inequality, and mortality. Am. J. Public Health. 87(9):1997;1491-1498.
54. Kennedy B.P., Kawachi I., Brainerd E. The role of social capital in the Russian mortality crisis. World Dev. 26:1998;2029-2043.
55. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder. JAMA. 289(23):2003;3095-3105.
56. Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Emotions morbidity and mortality. New perspective from psychoneuroimmunology. 53:2002;83-107.
57. S.S. Knox, M. Viigma, A.L. Unden, S. Elofson, J. Johansson, Psychosocial factors and cardiovascular risk in the East-West divide: the Swestonia study, in: G. Weidner, M.S. Kopp, M. Kristenson (Eds.), Heart Disease: Environment, Stress and Gender. NATO Science Series, Life and Behavioural Sciences, vol. 327, IOS Press, Amsterdam, 2002, pp. 138-152.
58. Kopp M. Psychophysiology of anxiety (In Hungarian) Ideggy. Szemle. 35:1982;193-202.
59. Kopp M. Anxiety. Behav. Psychother. 18:1990;193-206.
60. Kopp M. Behavioural medicine in health promotion. Acta Physiol. Hung. 86(3/4):1999;191-197.
61. M.S. Kopp, (Interview) stress:the invisible hand in Eastern Europe's death rates, Science 288 (2000) 1732-1733.
62. M.S. Kopp, Cultural transition, in: E.G. Fink (Ed.), Encyclopedia of Stress, vol. 1, Academic Press, San Diego, 2000, pp. 611-615.
63. Kopp M.S., Appels A., Szedmák S. Depressive symptomatology and vital exhaustion are differentially related to behavioural risk factors for coronary artery disease. Psychosom. Med. 60:1998;752-758.
64. Kopp M.S., Arató M., Magyar I., Buza K. Basal-adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients. Int. J. Psychophysiol. 7:1989;77-83.
65. Kopp M.S., Litavszky Z.S., Temesvári Á. The role of dissociation between cardiorespiratory and metabolic responses in angina-like chest pain panic patients. Behav. Psychother. 24:1996;235-246.
66. Kopp M., Prékopa A., Skrabski Á. Game theory model of dysthymic and hysteric neurosis (in Hungarian) Ideggy. Szmle. 31:1978;154-165.
67. Kopp M., Skrabski Á. What does the legacy of Hans Selye and Franz Alexander mean today? (The Psychophysiological approach in medical practice). Int. J. Psychophysiol. 8:1989;99-105.
68. M.S. Kopp, Á. Skrabski, Behavioural Sciences Applied to A Changing Society. Bibl Septem Artium Liberalium, Budapest, 1996.
69. M.S. Kopp, Á. Skrabski, J. Lõke, S. Szedmák, The Hungarian state of mind in a transforming society, in: Zs. Spéder (Ed.), Hungary in Flux, Society, Politics and Transformation, Verlag Dr. Reinhold Kramer, Hamburg, 1999, pp. 117-134.
70. Kopp M.S., Skrabski Á., Szedmák S. Socioeconomic factors, severity of depressive symptomatology and sickness absence rate in the Hungarian population. J. Psychosom. Res. 39(8):1995;1019-1029.
71. Kopp M.S., Skrabski Á., Szedmák S. Psychosocial risk factors, inequality and self-rated morbidity in a changing society. Soc. Sci. Med. 51:2000;1350-1361.
72. M.S. Kopp, Á. Skrabski, S. Szedmák, The influence of societal structure on depressive symptomatology and morbidity in the Hungarian population, in: W. Wosinska, R.B. Cialdini, J. Reykowski, D.W. Barrett (Eds.), The Practice of Social Influence in Multiple Cultures, Lawrence Erlbaum, 2001, pp. 207-221.
73. M.S. Kopp, Á. Skrabski, A. Székely, Risk factors and inequality in relation to morbidity and mortality in a changing society, in: G. Weidner, M.S. Kopp, M. Kristenson (Eds.), Heart Disease: Environment, Stress and Gender. NATO Science Series, Life and Behavioural Sciences, vol. 327, IOS Press, Amsterdam, 2002, pp. 101-113.
74. M.S. Kopp, S. Szedmák, A. Skrabski, Socioeconomic differences and psychosocial aspects of stress in a changing society, in: P. Csermely (Ed.), Stress of Life from Molecules to Man, Ann. N.Y. Acad. Sci. 85 (1998) 538-543.
75. Krantz D.S., McCeney M.K. Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease. Annu. Rev. Psychol. 53:2002;341-369.
76. M. Kristenson, Z. Kucinskiene, Possible causes of the differences in coronary heart disease mortality between Lithuania and Sweden: the LiuViCordia study, in: G. Weidner, M.S. Kopp, M. Kristenson (Eds.), Heart Disease: Environment, Stress and Gender, NATO Science Series, Life and Behavioural Sciences, vol. 327, IOS Press, Amsterdam, 2002, pp. 328-340.
77. Kristenson M., Kucinskiene Z., Bergdahl B., Calkauskas H., Urmonas V., Orth-Gomer K. Increased psychosocial strain in Lithuanian versus Swedish men: the LiVicordia study. Psychosom. Med. 60(3):1998;277-282.
78. Kubzansky L.D., Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease? J. Psychosom. Res. 48:2000;323-337.
79. Lahelma E., Valkonen T. Health and social inequities in Finland and elsewhere. Soc. Sci. Med. 31:1990;257-265.
80. Lantz P.M., House J.S., Lepkowsky J.M., Williams D.R., Mero R.P., Chen J. Socioeconomic factors, health behaviors, and mortality. JAMA. 279:1998;1703-1708.
81. Lawlor D.A., Ebrahim S., Davey-Smith G. Socioeconomic position in childhood and adulthood and insuline resistance: cross sectional survey using data from British women's heart and health study. Br. Med. J. 325:2002;805-807.
82. R.S. Lazarus, S. Folkman, Stress, Appraisal and Coping, Springer, New York, 1984.
83. Linden W., Stossel C., Maurice J. Psychosocial interventions for patients with coronary artery disease. Arch. Intern. Med. 156:1996;745-752.
84. Mackenbach J.P., Kunst A.E., Groenhof F., Borgan J.K., Costa G., Faggiano F., Józan P., Leinsalu M., Martikainen P., Rychtarikova J., Valkonen T. Socioeconomic inequalities in mortality among women and among men: an international study. Am. J. Public Health. 89(12):1999;1800-1806.
85. Majess R.B., Barden H., Ettinger M., Schultz F. Bone density of the radius, spine and proximal femurin osteoporosis. J. Bone Miner. Res. 3:1988;13-18.
86. M. Marmot, R. Wilkinson, Social Determinants of Health, Oxford Univ. Press, 1999.
87. M.G. Marmot, The social pattern of health and disease, in: D. Blane, E. Brunner, R. Wilkinson (Eds.), Health and Social Organization Rutledge, 1996, pp. 42-70.
88. Marmot M.G., Kogevinas M., Elston M.A. Social/economic status and disease. Ann. Rev. Public Health. 8:1987;111-135.
89. Marmot M.G., Smith G.D., Stansfeld S., Patel C., North F., Head J., White I., Brunner E., Feeney A. Health inequalities among British servants: the Whitehall II study. Lancet. 337:1991;387-1393.
90. K. Matthews, Depression models, in: E.G. Fink (Ed.), Encyclopedia of Stress, vol. 1, Academic Press, New York, 2000, pp. 675-682.
91. Mayou R.A., Gill D., Tompson D.R., Day A., Hick N., Volmink J., Neil A. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom. Med. 62:2000;212-219.
92. Mazur A., Booth A. Testosterone and dominance in men. Behav. Brain Sci. 21:1998;353-397.
93. McCarty M.F. High dose piridoxine as an "anti-stress" strategy. Med. Hypotheses. 54(5):2000;803-807.
94. McEwen B.S. Protective and damaging effects of stress mediators. N. Eng. J. Med. 338:1998;171-179.
95. McGee H.M., Hevey D., Horgan J.H. Psychosocial outcome assessments for use in cardiac rehabilitation service evaluation: a 10 year systematic review. Soc. Sci. Med. 48:1999;1373-1393.
96. Michelson D., Stratakis C., Hill I., Reynolds J., Gallivan E., Choroussos G. Bone mineral density in women with depression. N. Engl. J. Med. 335:1996;1176-1181.
97. Minor T.R., Rowe M.K., Job R.F.S., Ferguson E.C. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav. Brain Res. 120:2001;203-212.
98. Mizoguchi K., Kunishita T., Chui D.H., Tabira T. Stress induced neuronal death in the hippocampus of castrated rats. Neurosci. Lett. 138:1992;157-160.
99. Murphy J.M., Monson R.R., Olivier D.C., Sobol A.M., Leighton A.H. Affective disorders and mortality. Arch. Gen. Psychiatry. 44:1987;473-480.
100. Murphy J.M., Olivier D.C., Monson P.R., Sobol A.M., Federman E.B., Leighton A.H. Depression and anxiety in relation to social status. Arch. Gen. Psychiatry. 48:1991;223-229.
101. C.J.L. Murray, A.D. Lopez, The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and Projected to 2020, Harvard University Press, Cambridge, 1996.
102. Musselmann D.L., Evans D., Nemeroff Ch.B. The relationship of depression to cardiovascular disease. Arch. Gen. Psychiatry. 55:1998;580-592.
103. National Heart, Lung and Blood Institute Report of the Task Force on Behavioral Research in Cardiovascular, Lung and Blood Health and Disease, February, 1998.
104. Ornish D., Brown S.E., Scherwitz L.W., Billings J.H., Armstrong W.T., Ports T.A., McLanahan S.M., Kirkeeide R.L., Brand R.J., Gould K.L. Can lifestyle changes reverse coronary heart disease? Lancet. 336:1990;129-133.
105. Ornish D., Scherwitz L.W., Billings J.H., Gould K.L., Merritt T.A., Sparler S., Armstrong W.T., Ports T.A., Kirkeide R.L., Hogeboom C., Brand R.J. Intensive lifesyle changes for reversal of coronary heart disease. JAMA. 280(23):1998;2001-2007.
106. Penninx B.W.J., Beekman A.T.F., Honig A., Deeg D.J.H., Schoevers R.A., van Eijk J.T.M., van Tilburg W. Depression and cardiac mortality. Arch. Gen. Psychiatry. 58:2001;221-227.
107. Petty F., Kramer G., Wilson L., Chae Y.L. Learned helplessness and in vivo hippocampal noepinephrine release. Pharmacol. Biochem. Behav. 46:1993;231-235.
108. Petty F., Kramer G.L., Wu J., Davis L.L. Posttraumatic stress and depression, a neurochemical model of the learned animal helplessness model. Ann. N. Y. Acad. Sci. 84:1997;529-532.
109. Piko B.F. Socio-cultural stress in modern societies and the myth of anxiety in Eastern-Europe. Admin. Policy Mental Health. 29(3):2002;275-280.
110. Pratt L.A., Ford D.E., Crum R.M., Armenian H.K., Gallo J.J., Eaton W.W. Depression, psychotropic medication and risk of myocardial infarction, prospective data from the Baltimore ECA follow-up. Circulation. 94:1996;3123-3129.
111. Price J. The adaptive function of mood change. Br. J. Med. Psychol. 71:1998;465-477.
112. Price J., Sloman L., Gardner R., Gilbert P., Rohde P. The social competition hypothesis of depression. Br. J. Psychiatry. 164:1994;309-315.
113. Priorities for Public Health. EU Commission, Paris, 1999.
114. R.H. Rahe, Coping and Stress, in: E.G. Fink (Ed.), Encyclopedia of Stress, vol. 1, Academic Press, New York, 2000, pp. 541-546.
115. Réthelyi J., Berghammer R., Kopp M.S. Comorbidity of pain-associated disability and depressive symptoms in connection with sociodemographic variables: results from a cross-sectional epidemiological survey in Hungary. Pain. 93(2):2001;115-121.
116. Rohleider N., Schommer N.C., Hellhammer D.H., Engel R., Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production afterpsychosocial stress. Psychosom. Med. 63:2001;966-972.
117. Ronan P.J., Steiciuk M., Kramer G.L., Kram M., Petty F. Increased septal 5-HIAA efflux in rats that do not develop learned helplessness after inescapable stress. J. Neurosci. Res. 61:2000;101-106.
118. Rozansky A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 99:1999;2192-2217.
119. Ruo B., Rumsfeld J.S., Hlatky M.A., Liu H., Browner W.S., Whooley M.A. Depressive symptoms and health related quality of life. The heart and soul study. JAMA. 290(2):2003;215-221.
120. W. Rutz, Updating the Gotland study. Focus on male depression, Joint Scientific Meeting of the Swedish and Hungarian PTD Groups, 5th December, Budapest, Hungary, 1998.
121. W. Rutz, Gotland scale of Male Depression (Personal Communication), 2000.
122. Sapolsky R.M. Hypercorticolism among socially subordinate wild baboons originates at the CNS level. Arch. Gen. Psychiatry. 46:1989;1047-1051.
123. R.M. Sapolsky, Stress in the Wild, Scientific American, 1990, pp. 106-113.
124. Sapolsky R.M. Adrenocortical function, social rank, and personality among wild baboons. Biol. Psychiatry. 28:1990;862-878.
125. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr. Rev. 21(1):2000;55-89.
126. Schurr A. Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. NeNeurochem. Int. 41(1):2002;1-8.
127. Schurr A. Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem. Int. 41(1):2002;1-8.
128. Schweiger U., Deuschle M., Korner A., Lammers C.H., Schmider J., Gotthard U. Low lumbar bone mineral density in patients with major depression. Am. J. Psychiatry. 151:1994;1691-1693.
129. M.E.P. Seligman, Helplessness: On Depression, Development and Death, Freeman, W.H., San Francisco, 1975.
130. M.E.P. Seligman, D.M. Isaacowitz, Learned helplessness, in: E.G. Fink (Ed.), Encyclopedia of Stress, vol. 2, Academic Press New York, 2000, pp. 599-603.
131. H. Selye, Stress in Health and Disease, Betterworth, Boston, 1976.
132. Selye H. A syndrome produced by diverse noxious agent. Nature. 138:1936;32-45.
133. Sesso H.D., Kawachi I., Vokonas P.S., Sparrow D. Depression and the risk of coronary heart disease in the normative aging study. Am. J. Cardiol. 82:1998;851-856.
134. J. Siegrist, Adverse health effects of effort-reward imbalance-applying the model to Eastern Europe, in: G. Weidner, M.S. Kopp, M. Kristenson (Eds.), Heart Disease: Environment, Stress and Gender, NATO Science Series, Life and Behavioural Sciences, vol. 327, IOS Press, Amsterdam, 2002, pp. 26-38.
135. Sklar L., Anisman H. Stress and coping factors influence tumour growth. Science. 205:1979;513-515.
136. Skrabski Á., Kopp M.S., Kawachi I. Social capital in a changing society: cross sectional associations with middle aged female and male mortality. J. Epidemiol. Commun. Health. 57:2003;114-119.
137. Á. Skrabski, M.S. Kopp, I. Kawachi, Social capital and collective efficacy in Hungary: cross-sectional associations with middle-aged female and male mortality rates, J. Epidemiol. Community Health, in press.
138. Slater C.H., Lorimer R.J., Larison D.R. The independent contribution of socioeconomic status and health practices to health status. Prev. Med. 14:1985;372-373.
139. Song C. The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatment. Hum. Psychopharmacol. Clin. Exp. 15:2000;199-211.
140. Söti C.s., Csermely P. Chaperones and aging: role in neurodegeneration and other civilizational diseases. Neurochem. Int. 41:2002;383-389.
141. A. Steptoe, Psychobiological stress response, in: M. Johnston, L. Wallace (Eds.), Stress and Medical Procedures, Oxford University Press, Oxford, 1990.
142. A. Steptoe, Control and stress, in: E.G. Fink (Ed.), Encyclopedia of Stress, vol. 1, Academic Press, New York, 2000, pp. 526-532.
143. Stewart W.F., Ricci J.A., Chee E., Hahn S.R., Morgenstein D. Cost of lost productive work time among US workers with depression. JAMA. 289(23):2003;3135-3144.
144. P.E. Stokes, The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression, Eur. Neuropsychopharmacol. Suppl. (1995) 77-82.
145. Suarez E.C., Krishnan R.R., Lewia J.G. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med. 65:2003;362-368.
146. M.H. Teicher, Scars that won't heal: the neurobiology of child abuse, Sci. Am. (2002) 54-61.
147. Uno H., Tarara R., Else J., Suleman M., Sapolsky R. Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci. 9:1989;1705-1711.
148. Vizi E.S. Receptor mediated local fine tuning by noradrenergic innervation of neuroendocrin and immune systems. Ann. N. Y. Acad. Sci. 851:1998;388-396.
149. Vizi E.S., Elenkov I.J. Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biologica Hungarica. 53(1/2):2002;229-244.
150. Von Kanel R., Mills P.J., Fainman C., Dimsdale J.E. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom. Med. 63:2001;531-544.
151. Weich S., Lewis G., Jenkins S.P. Income inequality and the prevalence of common mental disorders in Britain. Br. J. Psychiatry. 178:2001;222-227.
152. G. Weidner, The role of stress and gender related factors in the increase in heart disease in Eastern Europe: overview, in: G. Weidner, M.S. Kopp, M. Kristenson (Eds.), Heart Disease: Environment, Stress and Gender. NATO Science Series, Life and Behavioural Sciences, vol. 327, IOS Press, Amsterdam, 2002, pp. 1-14.
153. M.A. Whitehead, European perspective, in: P. Townsend, N. Davidson, (Eds.), Inequalities in Health, Penguin, 1992, pp. 294.
154. Whiteman M.C., Deary I.J., Fowkes F.G.R. Psychological factors and peripheral arterial disease. Crit. Ischemia. 9(1):1999;14-19.
155. R.G. Wilkinson, Health, civic society in Eastern Europe before 1989, in: C. Hertzman (Ed.), Environmental and Non-environmental Determinants of the East-West Life Expectancy Gap, Kluwer, Amsterdam, 1996.
156. Wilkinson R.G. National mortality rates: the impact of inequality? Am. J. Public Health. 82(8):1996;1082.
157. Wiley J.A., Comacho T.C. Life-style and future health: evidence from the Alameda county study. Prev. Med. 9:1986;1-21.
158. Wirtz P.H., von Kanel R., Schnorpfeil P., Ehlert U., Frey K., Fischer J.E. Reduced glucocorticoid sensitivity of monocyte interleukin 6 production in male industrial employees who are vitally exhausted. Psychosom. Med. 65:2003;672-678.
159. World Health Report 2001, Geneva, WHO, 2001.
160. WHO Europe Mental Health, State of the Art Paper, Geneva, WHO, 2000, 2001.
161. World Health Statistics Annual. Geneva, WHO, 1992.
162. C.B. Wortman, J.W. Brehm, Responses to uncontrollable outcomes: an integration of reactance theory and the learned helplessness model, in: L. Berkowitz (Ed.), Advances in Experimental Psychology, vol. 8, Academic Press, New York, 1975, pp. 277-336.